0 (0%) | 09-27 09:27 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 15.79 | 1-year : | 18.44 |
Resists | First : | 13.52 | Second : | 15.79 |
Pivot price | 13.04 ![]() |
|||
Supports | First : | 11.9 | Second : | 10.9 |
MAs | MA(5) : | 13.4 ![]() |
MA(20) : | 12.94 ![]() |
MA(100) : | 12.74 ![]() |
MA(250) : | 13.14 ![]() |
|
MACD | MACD : | 0.3 ![]() |
Signal : | 0.3 ![]() |
%K %D | K(14,3) : | 93.4 | D(3) : | 92.7 ![]() |
RSI | RSI(14): 65.6 | |||
52-week | High : | 16 | Low : | 10.64 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ LBAI ] has closed below upper band by 24.3%. Bollinger Bands are 18.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 13.54 - 13.61 | 13.61 - 13.66 |
Low: | 12.93 - 13.01 | 13.01 - 13.06 |
Close: | 13.32 - 13.44 | 13.44 - 13.53 |
Fri, 12 Sep 2025
$LBAI Token Is Getting Listed On The LCX Exchange - LCX
Fri, 18 Apr 2025
Thesis | B Lymphocytes, Autoimmunity and Immunotherapies - UMR 1227 - UBO | Université de Bretagne Occidentale
Tue, 26 Mar 2024
Provident (PFS) & Lakeland (LBAI) Get Conditional Nod for Merger - Yahoo Finance
Thu, 25 Jan 2024
Lakeland Bancorp: Q4 Earnings Snapshot - qz.com
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 65 (M) |
Shares Float | 62 (M) |
Held by Insiders | 5.4 (%) |
Held by Institutions | 62.5 (%) |
Shares Short | 1,220 (K) |
Shares Short P.Month | 1,180 (K) |
EPS | 1.28 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 18.1 |
Profit Margin | 29.2 % |
Operating Margin | 38.5 % |
Return on Assets (ttm) | 0.7 % |
Return on Equity (ttm) | 7.3 % |
Qtrly Rev. Growth | -5.4 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 4.44 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 103 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 10.41 |
PEG Ratio | 1.2 |
Price to Book value | 0.74 |
Price to Sales | 3.01 |
Price to Cash Flow | 8.45 |
Dividend | 0.14 |
Forward Dividend | 0 |
Dividend Yield | 1% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |